Sartorius Stedim Biotech SA (SRTOY)
23.29
-0.99
(-4.08%)
USD |
OTCM |
Oct 08, 16:00
Sartorius Stedim Biotech Profit Margin (Quarterly) : 12.24% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.24% |
| March 31, 2026 | 11.57% |
| December 31, 2025 | 6.11% |
| September 30, 2025 | 9.17% |
| June 30, 2025 | 9.21% |
| March 31, 2025 | 11.47% |
| December 31, 2024 | 6.16% |
| September 30, 2024 | 4.01% |
| June 30, 2024 | 6.88% |
| March 31, 2024 | 8.53% |
| December 31, 2023 | 4.68% |
| September 30, 2023 | 5.25% |
| June 30, 2023 | 19.70% |
| March 31, 2023 | 15.36% |
| December 31, 2022 | 21.31% |
| September 30, 2022 | 22.91% |
| June 30, 2022 | 24.91% |
| March 31, 2022 | 31.35% |
| December 31, 2021 | 0.88% |
| September 30, 2021 | 19.34% |
| June 30, 2021 | 21.34% |
| March 31, 2021 | 19.55% |
| December 31, 2020 | 18.09% |
| September 30, 2020 | 19.91% |
| June 30, 2020 | 15.10% |
| Date | Value |
|---|---|
| March 31, 2020 | 17.89% |
| December 31, 2019 | 15.18% |
| September 30, 2019 | 16.09% |
| June 30, 2019 | 17.77% |
| March 31, 2019 | 16.48% |
| December 31, 2018 | 21.53% |
| September 30, 2018 | 16.04% |
| June 30, 2018 | 16.64% |
| March 31, 2018 | 14.73% |
| December 31, 2017 | 16.12% |
| September 30, 2017 | 14.52% |
| June 30, 2017 | 14.54% |
| March 31, 2017 | 15.14% |
| December 31, 2016 | 12.97% |
| September 30, 2016 | 16.07% |
| June 30, 2016 | 15.13% |
| March 31, 2016 | 15.05% |
| December 31, 2015 | 11.14% |
| September 30, 2015 | 17.12% |
| June 30, 2015 | 15.35% |
| March 31, 2015 | 9.54% |
| December 31, 2014 | 10.22% |
| September 30, 2014 | 11.76% |
| June 30, 2014 | 11.05% |
| March 31, 2014 | 10.13% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -18.02% |
| Sanofi | -- |
| Codexis, Inc. | -80.49% |
| Nicox SA | -- |
| Evotec SE | -32.51% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.14% |
| Return on Assets | 3.65% |
| Return on Invested Capital | 4.36% |
| Gross Profit Margin (Quarterly) | 46.86% |
| Operating Margin (Quarterly) | 20.92% |
| Return on Net Operating Assets | 3.99% |